Home and Alternate Site Infusion Therapy Market

Home and specialty infusion is a vast arena of pharmaceutical services provided in the outpatient setting, typically in the patient?s home or an infusion suite. The majority of these medications involve administration through a needle or catheter, otherwise known as infusion, while others are administered via alternate routes of administration such as intramuscular, epidural, and self-injectable means. Infusion medications are prescribed for both acute and chronic illnesses that cannot be effectively treated with oral medications alone. Patients may shorten or avoid stays in institutions such as hospitals and nursing homes when their infusion therapy can be provided in alternate-site settings including their homes and ambulatory infusion centers.

Home and Alternate Site Infusion Therapy Market aims to provide a comprehensive presentation of the global market for Home and Alternate Site Infusion Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Home and Alternate Site Infusion Therapy. Home and Alternate Site Infusion Therapy Market contains market size and forecasts of Home and Alternate Site Infusion Therapy in global, including the following market information:

Global Home and Alternate Site Infusion Therapy Market Revenue, 2018-2023, 2024-2035, ($ millions)

Global top five companies in 2022 (%)

The global Home and Alternate Site Infusion Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

Chemotherapy Segment to Reach $ Million by 2035, with a % CAGR in next six years.

The global key manufacturers of Home and Alternate Site Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica and Cleveland Clinic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Home and Alternate Site Infusion Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Home and Alternate Site Infusion Therapy Market, by Type, 2018-2023, 2024-2035 ($ millions)

Global Home and Alternate Site Infusion Therapy Market Segment Percentages, by Type, 2022 (%)

Chemotherapy

Anti-infective Therapies

Immune Therapy

General Nursing Services

Others

Global Home and Alternate Site Infusion Therapy Market, by Application, 2018-2023, 2024-2035 ($ millions)

Global Home and Alternate Site Infusion Therapy Market Segment Percentages, by Application, 2022 (%)

Residential

Ambulatory Infusion Centers

Others

Global Home and Alternate Site Infusion Therapy Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)

Global Home and Alternate Site Infusion Therapy Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Home and Alternate Site Infusion Therapy revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies Home and Alternate Site Infusion Therapy revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Option Care Health

Coram CVS

UnitedHealth Group

HCA Healthcare

McLaren

CHI Health

Accredo Health

PharMerica

Cleveland Clinic

Outline of Major Chapters:

Chapter 1: Introduces the definition of Home and Alternate Site Infusion Therapy, market overview.

Chapter 2: Global Home and Alternate Site Infusion Therapy market size in revenue.

Chapter 3: Detailed analysis of Home and Alternate Site Infusion Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Home and Alternate Site Infusion Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.